NCT00486343View on ClinicalTrials.gov

Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS

PHASE4TerminatedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Asthma
Interventions
DRUG

Zileuton CR

Zileuton CR tablets 2x600mg BID for 24 weeks

DRUG

Placebo

Placebo tablets 2x600mg BID for 24 weeks

Trial Locations (1)

02421

Critical Therapeutics, Lexington

Sponsors
All Listed Sponsors
lead

Critical Therapeutics

INDUSTRY